News

Filter

Current filters:

None

37 to 46 of 97925 results

Bavarian Nordic set to earn $975 million in Prostvac deal

Bavarian Nordic set to earn $975 million in Prostvac deal

04-03-2015

Danish biotech firm Bavarian Nordic has granted US pharma major Bristol-Myers Squibb an exclusive option…

Bavarian NordicBiotechnologyBristol-Myers SquibbLicensingOncologyProstvacVaccinesYervoy

First launch for Eisai’s Lenvima, in the USA

First launch for Eisai’s Lenvima, in the USA

03-03-2015

The US subsidiary of Japanese pharma major Eisai has now launched its in-house developed novel anticancer…

EisailenvatinibLenvimaMarkets & MarketingOncologyPharmaceuticalRare diseases

Mylan sales and revenue up while EpiPen becomes its first $1 billion-selling product

Mylan sales and revenue up while EpiPen becomes its first $1 billion-selling product

03-03-2015

US generic drugmaker Mylan has reported strong growth throughout the company for the fourth quarter and…

FinancialGenericsMylanPharmaceutical sciencesUSA

Lilly licenses pomaglumetad methionil to Denovo as potential schizophrenia therapy

Lilly licenses pomaglumetad methionil to Denovo as potential schizophrenia therapy

03-03-2015

US drug major Eli Lilly has licensed late-stage neuroscience drug pomaglumetad methionil (mGlu2/3 receptor…

Eli LillyLicensingNeurologicalPharmaceuticalpomaglumetad methionilUSA

Blueprint Medicines in up to $265 million deal with Alexion

03-03-2015

Privately-held Blueprint Medicines has entered a strategic collaboration with USA-based Alexion Pharmaceuticals…

Alexion PharmaceuticalsBlueprint MedicinesLicensingPharmaceuticalRare diseases

Oncolytics Biotech gains third orphan status for Reolysin

Oncolytics Biotech gains third orphan status for Reolysin

03-03-2015

Canada’s Oncolytics Biotech revealed today that the US Food and Drug Administration has granted Orphan…

BiotechnologyOncologyOncolytics BiotechRare diseasesRegulationReolysinUSA

Sun Pharma to buy GSK’s opiates business in Australia

Sun Pharma to buy GSK’s opiates business in Australia

03-03-2015

UK pharma major GlaxoSmithKline and India’s largest drugmaker by sales, Sun Pharmaceutical Industries,…

AustraliaGlaxoSmithKlineMergers & AcquisitionsNeurologicalPharmaceuticalSun Pharmaceutical Industries

FDA declines to expand approval of Pacira's Exparel for postsurgical analgesia

FDA declines to expand approval of Pacira's Exparel for postsurgical analgesia

03-03-2015

The US Food and Drug Administration has declined to expand the approval of Exparel (bupivacaine), manufactured…

AnalgesiaExparelPacira PharmaceuticalsPharmaceuticalRegulationUSA

37 to 46 of 97925 results

COMPANY SPOTLIGHT

Menarini

Back to top